Literature DB >> 9173680

Ethnic-related differences in coumarin 7-hydroxylation activities catalyzed by cytochrome P4502A6 in liver microsomes of Japanese and Caucasian populations.

T Shimada1, H Yamazaki, F P Guengerich.   

Abstract

1. Interethnic differences in cytochrome P4502A6 (CYP2A6) levels and coumarin 7-hydroxylation activities were determined in liver microsomes of 30 Japanese and 30 Caucasians. 2. Although CYP2A6 levels and coumarin 7-hydroxylation activities varied very significantly in the 60 human samples examined, both CYP2A6 levels and coumarin 7hydroxylation activities were found to be higher in Caucasian than Japanese population. 3. Interestingly, eight of the 30 Japanese examined showed very low or undetectable levels of coumarin 7-hydroxylation activities as well as of CYP2A6 in liver microsomes. All of the Caucasians, however, had significant CYP2A6 levels and variable 7-hydroxylation activities. 4. Kinetic analvsis of coumarin 7-hydroxylation activities in liver microsomes of various human samples suggested that although there were 260-fold differences in Vmax's in 10 human samples examined, the Km's were very similar (2.1 + or - 107 mu M); a value consistent with that obtained (1.2 mu M) with purified CYP2A6 in reconstituted system. 5. The results suggest that CYP2A6 is actually involved in the 7-hydroxylation of coumarin in human liver microsomes, and that interethnic differences in coumarin 7-hydroxylation activities in Japanese and Caucasian population may be ascribed to the differences in expression of CYP2A6 protein.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9173680     DOI: 10.3109/00498259609046718

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  18 in total

Review 1.  Polymorphisms of CYP2A6 and its practical consequences.

Authors:  H Raunio; A Rautio; H Gullstén; O Pelkonen
Journal:  Br J Clin Pharmacol       Date:  2001-10       Impact factor: 4.335

2.  Metabolic capabilities of cytochrome P450 enzymes in Chinese liver microsomes compared with those in Caucasian liver microsomes.

Authors:  Junling Yang; Minxia M He; Wei Niu; Steven A Wrighton; Li Li; Yang Liu; Chuan Li
Journal:  Br J Clin Pharmacol       Date:  2012-02       Impact factor: 4.335

3.  Metabolic activation of polycyclic aromatic hydrocarbons and aryl and heterocyclic amines by human cytochromes P450 2A13 and 2A6.

Authors:  Tsutomu Shimada; Norie Murayama; Hiroshi Yamazaki; Katsuhiro Tanaka; Shigeo Takenaka; Masayuki Komori; Donghak Kim; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2013-03-13       Impact factor: 3.739

Review 4.  S-1 in the treatment of pancreatic cancer.

Authors:  Kentaro Sudo; Kazuyoshi Nakamura; Taketo Yamaguchi
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

5.  An improved substrate cocktail for assessing direct inhibition and time-dependent inhibition of multiple cytochrome P450s.

Authors:  Zhong-Hua Chen; Su-Xing Zhang; Na Long; Li-Shan Lin; Tao Chen; Fei-Peng Zhang; Xue-Qin Lv; Pei-Zhen Ye; Ning Li; Ke-Zhi Zhang
Journal:  Acta Pharmacol Sin       Date:  2016-04-11       Impact factor: 6.150

6.  Development of a new predictive model for interactions with human cytochrome P450 2A6 using pharmacophore ensemble/support vector machine (PhE/SVM) approach.

Authors:  Max K Leong; Yen-Ming Chen; Hong-Bin Chen; Po-Hong Chen
Journal:  Pharm Res       Date:  2008-12-23       Impact factor: 4.200

Review 7.  Perspectives in the treatment of pancreatic adenocarcinoma.

Authors:  Angel Cid-Arregui; Victoria Juarez
Journal:  World J Gastroenterol       Date:  2015-08-21       Impact factor: 5.742

8.  Pharmacokinetic evaluation of novel oral fluorouracil antitumor drug S-1 in Chinese cancer patients.

Authors:  Zhi-xiang Zhuang; Hong Zhu; Ji Wang; Min-gao Zhu; Hui Wang; Wang-yang Pu; Hua-hui Bian; Lei Chen; Hong Zhang
Journal:  Acta Pharmacol Sin       Date:  2013-02-11       Impact factor: 6.150

9.  Squamous cell carcinoma of the extrahepatic bile duct with metachronous para-aortic lymph node metastasis successfully treated with S-1 plus cisplatin.

Authors:  Ryohei Nishiguchi; Dal Ho Kim; Masayuki Honda; Tsuguo Sakamoto
Journal:  BMJ Case Rep       Date:  2016-12-08

10.  Two dosages of oral fluoropyrimidine S-1 of 35 and 40 mg/m2 bid: comparison of the pharmacokinetic profiles in Korean patients with advanced gastric cancer.

Authors:  Hei-Cheul Jeung; Sun Young Rha; Sang Joon Shin; Joong Bae Ahn; Sung Hoon Noh; Jae Kyung Roh; Hyun Cheol Chung
Journal:  Jpn J Clin Oncol       Date:  2009-10-31       Impact factor: 3.019

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.